Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Landos Biopharma Inc | LABP | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 22,4799 | 10:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 22,4799 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2,50 - 22,84 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 22,4799 | USD |
Finanzwerte LABP
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 70,06M | 3,12M | - | 0 | -21,94M | -7,04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Landos Biopharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 25.3.2024 | 13:31 | PR Newswire (US) | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 25.3.2024 | 13:30 | GlobeNewswire Inc. | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 04.3.2024 | 22:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 04.3.2024 | 22:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14.2.2024 | 22:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 04.1.2024 | 14:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.11.2023 | 14:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.11.2023 | 14:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09.11.2023 | 14:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.9.2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.9.2023 | 14:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09.8.2023 | 14:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Landos Biopharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
LABP Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 21,90 | 22,84 | 21,90 | 22,28 | 8.215 | 0,5799 | 2,65% |
| 1 Monat | 21,60 | 22,84 | 21,43 | 21,65 | 18.812 | 0,8799 | 4,07% |
| 3 Monate | 5,45 | 22,84 | 4,83 | 17,61 | 26.335 | 17,03 | 312,48% |
| 6 Monate | 3,88 | 22,84 | 3,21 | 14,07 | 16.673 | 18,60 | 479,38% |
| 1 Jahr | 2,847 | 22,84 | 2,50 | 8,01 | 19.166 | 19,63 | 689,60% |
| 3 Jahre | 114,40 | 161,70 | 2,111 | 19,23 | 126.794 | -91,92 | -80,35% |
| 5 Jahre | 130,00 | 169,89 | 2,111 | 34,42 | 136.322 | -107,52 | -82,71% |
